AZI23'UTR Is a New SLC6A3 Downregulator Associated with an Epistatic Protection Against Substance Use Disorders
Kefu Liu(Fudan University), Zhicheng Lin(McLean Hospital), Jinlong Yu(Shanghai Jiao Tong University), Nian Xiong(Wuhan Union Hospital), Yanhong Zhou(Yanbian University Hospital), Richard L. Bell(Indiana University School of Medicine), Tao Wang(Tongji Hospital), Jie Xu(University of Michigan), Juan Zhao(Peking University), Hong Qing(Tongji University)
PMC
July 1, 2018
Cited by 0
Related Papers
Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis
|Journal of Medical Virology|2020|1.9k
Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects
|Frontiers in Aging Neuroscience|2018|378
Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models
|The Journal of Experimental Medicine|2008|363
Microglia as modulators of exosomal alpha-synuclein transmission
|Cell Death and Disease|2019|206